In this study, we constructed the Survivin promoter-regulated oncolytic adenovirus AdSurp-Hsp70, which mediated high Hsp70 expression in tumor cells, and we used this virus for gastric cancer-targeted gene therapy. The gene discussed is BIRC5; the disease is gastric cancer.